Revealing, in-depth interviews with executives that are driving growth and expanding the footprint of unique small-cap companies.
Episodes
Wednesday Jan 03, 2018
Wednesday Jan 03, 2018
Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) is an emerging pharmaceutical and IP development company publicly traded in Canada, the United States and Germany. Through its recently acquired 80 percent stake in Cannevert Therapeutics Ltd., also known as Veritas’ R&D arm, the company is clinically profiling various cannabis cultivars to pharmacologically connect unique strains with specific disease conditions. Veritas Pharma’s goal is to perform clinical trials to prove the efficacy of the designated lead cannabis strains and to market the clinically effective cultivars as prescription medicines in a fast-track protocol.